54 related articles for article (PubMed ID: 26396134)
21. B-9-3, a novel β-carboline derivative exhibits anti-cancer activity via induction of apoptosis and inhibition of cell migration in vitro.
Daoud A; Song J; Xiao F; Shang J
Eur J Pharmacol; 2014 Feb; 724():219-30. PubMed ID: 24380828
[TBL] [Abstract][Full Text] [Related]
22. Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion.
Foudah AI; Jain S; Busnena BA; El Sayed KA
ChemMedChem; 2013 Mar; 8(3):497-510. PubMed ID: 23404739
[TBL] [Abstract][Full Text] [Related]
23. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
24. Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cell.
Kim J; Lee YJ; Shin DS; Jeon SH; Son KH; Han DC; Jung SN; Oh TK; Kwon BM
Bioorg Med Chem; 2011 Dec; 19(24):7582-9. PubMed ID: 22071520
[TBL] [Abstract][Full Text] [Related]
25. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
[TBL] [Abstract][Full Text] [Related]
26. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation.
Harvey AJ; Crompton MR
Oncogene; 2003 Aug; 22(32):5006-10. PubMed ID: 12902983
[TBL] [Abstract][Full Text] [Related]
27. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
[TBL] [Abstract][Full Text] [Related]
28. Discovery of substituted 4-anilino-2-(2-pyridyl)pyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. Part 1: structure-activity relationships of the 4-anilino group.
Sirisoma N; Kasibhatla S; Nguyen B; Pervin A; Wang Y; Claassen G; Tseng B; Drewe J; Cai SX
Bioorg Med Chem; 2006 Dec; 14(23):7761-73. PubMed ID: 16919962
[TBL] [Abstract][Full Text] [Related]
29. Induction of caspase-dependent apoptosis by apigenin by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells.
Seo HS; Ku JM; Choi HS; Woo JK; Jang BH; Shin YC; Ko SG
Anticancer Res; 2014 Jun; 34(6):2869-82. PubMed ID: 24922650
[TBL] [Abstract][Full Text] [Related]
30. 3-benzylamino-β-carboline derivatives induce apoptosis through G2/M arrest in human carcinoma cells HeLa S-3.
Ikeda R; Iwaki T; Iida T; Okabayashi T; Nishi E; Kurosawa M; Sakai N; Konakahara T
Eur J Med Chem; 2011 Feb; 46(2):636-46. PubMed ID: 21194810
[TBL] [Abstract][Full Text] [Related]
31. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
32. Discovery, optimization, and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk/Paxillin/Rac1 axis.
Elsayed HE; Akl MR; Ebrahim HY; Sallam AA; Haggag EG; Kamal AM; El Sayed KA
Chem Biol Drug Des; 2015 Feb; 85(2):231-43. PubMed ID: 24954090
[TBL] [Abstract][Full Text] [Related]
33. The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges.
Harvey AJ; Crompton MR
Anticancer Drugs; 2004 Feb; 15(2):107-11. PubMed ID: 15075665
[TBL] [Abstract][Full Text] [Related]
34. Differential behaviour of cationic triphenylamine derivatives in fixed and living cells: triggering and imaging cell death.
Chennoufi R; Bougherara H; Gagey-Eilstein N; Dumat B; Henry E; Subra F; Mahuteau-Betzer F; Tauc P; Teulade-Fichou MP; Deprez E
Chem Commun (Camb); 2015 Oct; 51(80):14881-4. PubMed ID: 26303028
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer.
Jerin S; Harvey AJ; Lewis A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509364
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive review of α-carboline alkaloids: Natural products, updated synthesis, and biological activities.
Li D; Yang R; Wu J; Zhong B; Li Y
Front Chem; 2022; 10():988327. PubMed ID: 36092663
[TBL] [Abstract][Full Text] [Related]
37. Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro.
Burmi RS; Box GM; Wazir U; Hussain HA; Davies JA; Court WJ; Eccles SA; Jiang WG; Mokbel K; Harvey AJ
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327957
[TBL] [Abstract][Full Text] [Related]
38. Putting the BRK on breast cancer: From molecular target to therapeutics.
Ang HL; Yuan Y; Lai X; Tan TZ; Wang L; Huang BB; Pandey V; Huang RY; Lobie PE; Goh BC; Sethi G; Yap CT; Chan CW; Lee SC; Kumar AP
Theranostics; 2021; 11(3):1115-1128. PubMed ID: 33391524
[TBL] [Abstract][Full Text] [Related]
39. Targeting protein tyrosine kinase 6 in cancer.
Gilic MB; Tyner AL
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188432. PubMed ID: 32956764
[TBL] [Abstract][Full Text] [Related]
40. Novel 4-anilino-α-carboline derivatives induce cell death in nonadhesive breast cancer cells through inhibition of Brk activity.
Oelze M; Mahmoud KA; Sippl W; Wersig T; Hilgeroth A; Ritter CA
Int J Clin Pharmacol Ther; 2015 Dec; 53(12):1052-5. PubMed ID: 26396134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
